Role of HSD17B13 in NAFLD

Share post on social media:
Role of HSD17B13 in NAFLD

HSD17B13 (Hydroxysteroid 17-Beta Dehydrogenase 13) is a unique liver-specific lipid droplet associated protein found in humans.  Higher levels of HSD17B is associated with accumulation of fatty acid in the liver which is a common occurrence in advanced liver diseases such as NASH and NAFLD.  In a recent study, Anstee et al. showed the significance of PNPLA3 as a risk factor for NAFLD but also showed the important contribution of HSD17B13 & TM6SF2.  In addition to genome wide analysis, the study showed that HSD17B13 had retinol dehydrogenase activity. Learn more about  the impact on SNPs on enzyme activity and the disease NAFLD.  Download paper

You might also like...

View blog
New markers to distinguish well-differentiated liposarcoma from lipoma
3 min read
New markers to distinguish well-differentiated liposarcoma from lipoma
Well-differentiated liposarcoma is a malignant, non-metastasizing tumor that can present with similar histological characteristics as...
Lipid Nanoparticle (LNPs) formulation guide
1 min read
Lipid Nanoparticle (LNPs) formulation guide
Messenger RNA (mRNA) has shown therapeutic potential in a range of applications, including viral vaccines, cancer immunotherapies, protein...
Cayman LipiDOT Strips™ for the Rapid Screening of Protein-Lipid Interactions
5 min read
Cayman LipiDOT Strips™ for the Rapid Screening of Protein-Lipid Interactions
Our supplier Cayman Chemical has launched a new product: Cayman LipiDOT Strips™, a simple tool for the rapid identification of...